10.48
+0.62(+6.29%)
Currency In USD
| Previous Close | 9.86 |
| Open | 9.81 |
| Day High | 10.56 |
| Day Low | 9.77 |
| 52-Week High | 13.85 |
| 52-Week Low | 2.89 |
| Volume | 786,940 |
| Average Volume | 1.15M |
| Market Cap | 635.9M |
| PE | -13.61 |
| EPS | -0.77 |
| Moving Average 50 Days | 10 |
| Moving Average 200 Days | 7.39 |
| Change | 0.62 |
If you invested $1000 in CorMedix Inc. (CRMD) 10 years ago, it would be worth $659.12 as of February 05, 2025 at a share price of $10.48. Whereas If you bought $1000 worth of CorMedix Inc. (CRMD) shares 5 years ago, it would be worth $1,568.86 as of February 05, 2025 at a share price of $10.48.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
GlobeNewswire Inc.
Jan 21, 2025 1:00 PM GMT
BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces it has
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update
GlobeNewswire Inc.
Jan 07, 2025 12:30 PM GMT
‒ Q4 2024 Unaudited Net Revenue of Approximately $31mm ‒ ‒ FY 2024 Unaudited Net Revenue of Approximately $43mm ‒ ‒ Expects Q4 Adjusted EBITDA to Exceed $12mm ‒ BERKELEY HEIGHTS, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD),
CorMedix Inc. Added to Nasdaq Biotechnology Index
GlobeNewswire Inc.
Dec 19, 2024 1:30 PM GMT
BERKELEY HEIGHTS, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced it will